Data Reconciliation of Release Mechanism Research of LDH-Based Drug

Sebacate pillared layered double hydroxides (LDH) was prepared via co-precipitation method. And then the drug 10-hydroxy-camptothecin (10-HC) was intercalated into the gallery of LDH to form the drug–LDH composites. Three types of dissolution- diffusion kinetics models were used to make clear the drug release mechanism of the LDH composites. For the first time data reconciliation was used to make clear the drug release kinetics mechanism of the LDH composites, which was carried out by using a data filter algorithm based on first-order delay filter and time-delay principle to diminish random experimental errors resulting from the factors including stirring speed, solid content, and so on. Simulation results indicated that the data reconciliation adequately degraded the interactions between drug release rates at different times and made the data satisfy the kinetics models for the drug release mechanism more accurately.

[1]  R. Murthy,et al.  Novel method to evaluate diffusion controlled release of drug from resinate , 1986 .

[2]  W. Hou,et al.  Synthesis and release behavior of composites of camptothecin and layered double hydroxide , 2010 .

[3]  T. Kodama,et al.  SELECTIVE EXCHANGE AND FIXATION OF STRONTIUM IONS WITH ULTRAFINE NA-4-MICA , 2001 .

[4]  Zhang Chun-guang,et al.  Studies on Zero Point of Charge and Permanent Charge Density of Mg−Fe Hydrotalcite-like Compounds , 2001 .

[5]  Jae-Hun Yang,et al.  New inorganic-based drug delivery system of indole-3-acetic acid-layered metal hydroxide nanohybrids with controlled release rate , 2007 .

[6]  Fabrizio Cavani,et al.  Hydrotalcite-type anionic clays: Preparation, properties and applications. , 1991 .

[7]  Farid García,et al.  A Fast SVM Training Algorithm Based on a Decision Tree Data Filter , 2011, MICAI.

[8]  R. Srivastava,et al.  In-vitro release kinetics and stability of anticardiovascular drugs-intercalated layered double hydroxide nanohybrids. , 2009, The journal of physical chemistry. B.

[9]  Jane-Jen Wang,et al.  Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer. , 2006, Oncology reports.

[10]  X. Duan,et al.  A novel organic–inorganic microhybrids containing anticancer agent doxifluridine and layered double hydroxides: Structure and controlled release properties , 2010 .

[11]  E. Giannelis,et al.  Nanobiohybrids as delivery vehicles for camptothecin. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Renxin Zhong,et al.  DELAY‐DEPENDENT ROBUST CONTROL OF DESCRIPTOR SYSTEMS WITH TIME DELAY , 2006 .